Your browser doesn't support javascript.
loading
Response to "Letter regarding Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy".
Peters, Nils; Taasti, Vicki Trier; Ackermann, Benjamin; Bolsi, Alessandra; Dahlgren, Christina Vallhagen; Ellerbrock, Malte; Fracchiolla, Francesco; Gomà, Carles; Góra, Joanna; Lopes, Patricia Cambraia; Rinaldi, Ilaria; Salvo, Koen; Tarp, Ivanka Sojat; Vai, Alessandro; Bortfeld, Thomas; Lomax, Antony; Richter, Christian; Wohlfahrt, Patrick.
Affiliation
  • Peters N; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, B
  • Taasti VT; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands. Electronic address: vicki.taasti@maastro.nl.
  • Ackermann B; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Bolsi A; Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
  • Dahlgren CV; The Skandion Clinic, Uppsala, Sweden.
  • Ellerbrock M; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Fracchiolla F; Azienda Provinciale per i Servizi Sanitari (APSS) Protontherapy Department, Trento, Italy.
  • Gomà C; Department of Radiation Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Góra J; MedAustron Ion Therapy Center, Wiener Neustadt, Austria.
  • Lopes PC; HollandPTC, Delft, the Netherlands.
  • Rinaldi I; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Salvo K; AZ Sint-Maarten, Department of Radiotherapy, Mechelen, Belgium.
  • Tarp IS; Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus, Denmark.
  • Vai A; Radiotherapy Department, Center for National Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy.
  • Bortfeld T; Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA.
  • Lomax A; Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland.
  • Richter C; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany
  • Wohlfahrt P; Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA.
Radiother Oncol ; 190: 109961, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37871749

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proton Therapy Limits: Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proton Therapy Limits: Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Country of publication: